Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

What You Need to Know Ahead of Cencora's Earnings Release

With a market capitalization of $61.8 billion, Pennsylvania-based Cencora, Inc. (COR) is a leading global pharmaceutical services and drug distribution company, formerly known as AmerisourceBergen. It plays a critical role in the healthcare supply chain, acting as an intermediary between drug manufacturers and healthcare providers.

The company is expected to release its Q2 2026 earnings results on Tuesday, May 6, before the market opens. Ahead of this event, analysts anticipate Cencora to generate earnings of $4.81 per share, representing an increase of 8.8% from $4.42 per share reported in the same quarter last year. The company has surpassed the Street’s bottom-line estimates in each of the past four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.